Biocon’s Breakthrough Drug Itolizumab Receives DCGI Nod for its Use in Moderate to Severe COVID-19 Patients
Drug to Save Many Lives Bengaluru, Karnataka, India – July 11, 2020 Biocon Ltd. (BSE code: 532523, NSE: BIOCON), an ...
Read moreDrug to Save Many Lives Bengaluru, Karnataka, India – July 11, 2020 Biocon Ltd. (BSE code: 532523, NSE: BIOCON), an ...
Read more© 2018 | Fortune World Media | MEDIA & ENTERTAINMENT CO. IN | Powered by Raja's Digital
© 2018 | Fortune World Media | MEDIA & ENTERTAINMENT CO. IN | Powered by Raja's Digital